Foghorn Therapeutics (FHTX) Non-Current Assets (2019 - 2026)

Foghorn Therapeutics' Non-Current Assets history runs 8 years deep, the most recent figure standing at $34.1 million for Q1 2026.

• On a quarterly basis, Non-Current Assets rose 2.49% year-over-year to $34.1 million in Q1 2026; TTM through Mar 2026 was $112.2 million, a 21.95% decrease from a year earlier, with the FY2025 full-year figure at $34.9 million, up 1.42% from the prior year.
• Non-Current Assets eased to $34.1 million in Q1 2026 per FHTX's latest filing, from $34.9 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $58.5 million in Q1 2022 and bottomed at $20.8 million in Q3 2025.
• The 5-year median for Non-Current Assets is $43.5 million (2024), against an average of $42.3 million.
• Across the five-year window, Non-Current Assets slumped 43.87% in 2025 and rose 2.49% in 2026, its largest moves.
• Year by year, Non-Current Assets stood at $53.5 million in 2022, then declined by 14.49% to $45.7 million in 2023, then declined by 24.83% to $34.4 million in 2024, then gained by 1.42% to $34.9 million in 2025, then fell by 2.19% to $34.1 million in 2026.
• Per Business Quant, the three latest FHTX Non-Current Assets figures stand at $34.1 million (Q1 2026), $34.9 million (Q4 2025), and $20.8 million (Q3 2025).